BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 122904)

  • 1. [The mechanism of blood cell sedimentation. XVIII. Sedimentation effect of fibrinogen plasminolysis products].
    Hörmann H
    Blut; 1975 Jan; 30(1):51-8. PubMed ID: 122904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
    Plow E; Edgington TS
    J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The accelerating effect of fibrinogen and early fibrinogen degradation products on erythrocyte sedimentation.
    Marsh NA
    Thromb Haemost; 1979 Aug; 42(2):757-63. PubMed ID: 505378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of inhibition of fibrinolysis and fibrinogenolysis by the end fibrinogen degradation products.
    Khavkina LS; Rozenfeld MA; Leonova VB
    Thromb Res; 1995 Apr; 78(2):173-87. PubMed ID: 7482434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical method for separation of the active component from a mixture of early fibrinogen degradation products.
    Latallo ZS; Teisseyre E
    Scand J Haematol Suppl; 1971; 13():383-4. PubMed ID: 4258206
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of proteolytic enzymes on fibrinogen].
    Jamet M; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolysis and fibrinogenolysis by Val442-plasmin.
    Ney KA; Pizzo SV
    Biochim Biophys Acta; 1982 Nov; 708(2):218-24. PubMed ID: 6216916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinogen and fibrin split products and their biological importance].
    Krantz S; Fiedler H; Lober M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):1-13. PubMed ID: 4110779
    [No Abstract]   [Full Text] [Related]  

  • 10. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the terminal degradation products of canine fibrinogen by plasmin.
    Chen JP; Hutchison HT; Nanninga LB; Guest MM
    Biochim Biophys Acta; 1975 Mar; 386(1):69-79. PubMed ID: 123781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subfraction of fragment D isolated from a plasmin hydrolysate of human fibrinogen.
    Hörmann H
    Hoppe Seylers Z Physiol Chem; 1975 Dec; 356(12):1947-53. PubMed ID: 129428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
    Marder VJ; Budzynski AZ; Barlow GH
    Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
    Schwartz LB; Bradford TR; Littman BH; Wintroub BU
    J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin(-ogen) interactions with plasmin.
    Gaffney PJ
    Haemostasis; 1977; 6(1):2-25. PubMed ID: 140113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
    Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I
    Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron microscopic studies of plasmic degradation products of fibrinogen. Implications for the disulfide structure of fibrinogen.
    Tranqui-Pouit L; Marder VJ; Suscillon M; Budzynski AZ; Hudry-Clergeon G
    Biochim Biophys Acta; 1975 Aug; 400(2):189-99. PubMed ID: 126081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y).
    Nieuwenhuizen W; Voskuilen M; Hermans J
    Biochim Biophys Acta; 1982 Nov; 708(3):313-6. PubMed ID: 6216917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Vopr Med Khim; 1978; 24(2):255-60. PubMed ID: 149422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid sequence studies on the alpha chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site.
    Takagi T; Doolittle RF
    Biochemistry; 1975 Nov; 14(23):5149-56. PubMed ID: 127612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.